Lu Dan, Xia YuFeng, Tong Bei, Zhang ChaoFeng, Pan Rong, Xu Huan, Yang Xue, Dai Yue
China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University, Nanjing, China
Integr Cancer Ther. 2014 Sep;13(5):446-57. doi: 10.1177/1534735412442377. Epub 2012 Apr 13.
The anomalous fruits of Gleditsia sinensis Lam. (Leguminosae), a crude drug in China, have long been used in traditional Chinese medicine for the treatment of various diseases. The saponin fraction isolated from the fruits (SFGS) is considered as the active component for the antitumor activity of this crude drug.
The present study was performed to investigate the anti-angiogenesis activities and active constituents of SFGS.
Human umbilical vein endothelial cells (HUVECs) were treated with SFGS in the presence or absence of basic fibroblast growth factor (bFGF) in vitro. The proliferation, migration, and tube formation were studied by MTT, Transwell, and 2D Matrigel assays, respectively. The cell cycle and apoptosis were analyzed by flow cytometry. Enzyme-linked immunosorbent assay for protein expression of vascular endothelial growth factor (VEGF) and western blot analysis for caspase-3, caspase-8, and caspase-9 as well as Fas were performed. In addition, the effects of 13 saponin compounds isolated from SFGS on the tube formation of HUVECs were screened, and the structure-activity relationships were discussed.
SFGS, at concentrations (1, 3, and 10 µg/mL) without significant cytotoxicity on endothelial cells, significantly inhibited the proliferation, migration, and tube formation of HUVECs induced by bFGF (10 ng/mL). It moderately arrested the cell cycle to G1 phase but greatly induced cell apoptosis and increased the expressions of caspases-3, caspase-8, and Fas but not caspase-9 in HUVECs. Moreover, SFGS did not affect the bFGF-induced autosecretion of VEGF from endothelial cells. Among the 13 saponin compounds tested, gleditsiosides B, I, J, O, and Q showed inhibition of the tube formation at a concentration of 3 µM, and only gleditsioside B exerted significant inhibition at 1 µM.
SFGS is substantially able to prevent angiogenesis by interfering with multiple steps. The findings provide a new explanation for the antitumor effects of G sinensis fruits. Gleditsiosides B, I, J, O, and Q are probably the main active constituents of SFGS.
皂荚是中国一味中药材,其异形果实长期以来被用于治疗多种疾病。从果实中分离得到的皂苷组分(SFGS)被认为是该药材抗肿瘤活性的活性成分。
本研究旨在探讨SFGS的抗血管生成活性及活性成分。
体外在有或无碱性成纤维细胞生长因子(bFGF)存在的情况下,用SFGS处理人脐静脉内皮细胞(HUVECs)。分别通过MTT法、Transwell法和二维基质胶实验研究细胞增殖、迁移和管腔形成。通过流式细胞术分析细胞周期和凋亡情况。进行血管内皮生长因子(VEGF)蛋白表达的酶联免疫吸附测定以及半胱天冬酶-3、半胱天冬酶-8、半胱天冬酶-9和Fas的蛋白质印迹分析。此外,筛选了从SFGS中分离得到的13种皂苷化合物对HUVECs管腔形成的影响,并探讨了构效关系。
SFGS在对内皮细胞无明显细胞毒性的浓度(1、3和10μg/mL)下,显著抑制bFGF(10ng/mL)诱导的HUVECs增殖、迁移和管腔形成。它适度将细胞周期阻滞于G1期,但极大地诱导细胞凋亡,并增加HUVECs中半胱天冬酶-3、半胱天冬酶-8和Fas的表达,但不增加半胱天冬酶-9的表达。此外,SFGS不影响bFGF诱导的内皮细胞VEGF自分泌。在所测试的13种皂苷化合物中,皂荚皂苷B、I、J、O和Q在3μM浓度下显示出对管腔形成的抑制作用,只有皂荚皂苷B在1μM时表现出显著抑制作用。
SFGS能够通过干扰多个步骤有效预防血管生成。这些发现为皂荚果实的抗肿瘤作用提供了新的解释。皂荚皂苷B、I、J、O和Q可能是SFGS的主要活性成分。